A Study Comparing Two Formulations of Insulin Glargine in Healthy Participants
Clinical trial NCT02955953 · COMPLETED
Trial details
- NCT number
- NCT02955953
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-14
- Primary completion
- 2017-01-04
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.